Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy

NCT02173158 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Familial Hypercholesterolemia - Homozygous

Interventions

DRUG: lomitapide

Sponsor

Aegerion Pharmaceuticals, Inc.